Candriam SCA’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-680,812
| Closed | -$11.4M | – | 904 |
|
|
2021
Q1 | $11.4M | Sell |
680,812
-45
| -0% | -$751 | 0.09% | 232 |
|
|
2020
Q4 | $11.8M | Sell |
680,857
-27,193
| -4% | -$473K | 0.09% | 236 |
|
|
2020
Q3 | $13M | Buy |
708,050
+41,678
| +6% | +$764K | 0.12% | 184 |
|
|
2020
Q2 | $11.9M | Buy |
666,372
+328,577
| +97% | +$5.87M | 0.13% | 188 |
|
|
2020
Q1 | $5.95M | Buy |
337,795
+74
| +0% | +$1.3K | 0.07% | 305 |
|
|
2019
Q4 | $6.08M | Buy |
337,721
+165,802
| +96% | +$2.99M | 0.07% | 311 |
|
|
2019
Q3 | $3.48M | Buy |
171,919
+106,919
| +164% | +$2.17M | 0.05% | 394 |
|
|
2019
Q2 | $1.43M | Buy |
+65,000
| New | +$1.43M | 0.02% | 585 |
|
|
2018
Q2 | – | Sell |
-85,000
| Closed | -$939K | – | 798 |
|
|
2018
Q1 | $939K | Sell |
85,000
-56,000
| -40% | -$619K | 0.02% | 609 |
|
|
2017
Q4 | $1.24M | Sell |
141,000
-52,000
| -27% | -$458K | 0.02% | 553 |
|
|
2017
Q3 | $2.58M | Hold |
193,000
| – | – | 0.05% | 403 |
|
|
2017
Q2 | $2.77M | Sell |
193,000
-95,000
| -33% | -$1.36M | 0.05% | 395 |
|
|
2017
Q1 | $6.09M | Buy |
288,000
+22,000
| +8% | +$465K | 0.12% | 211 |
|
|
2016
Q4 | $7.49M | Buy |
266,000
+75,000
| +39% | +$2.11M | 0.17% | 152 |
|
|
2016
Q3 | $5.12M | Buy |
+191,000
| New | +$5.12M | 0.12% | 189 |
|
|
2015
Q3 | – | Sell |
-40,000
| Closed | -$1.16M | – | 625 |
|
|
2015
Q2 | $1.16M | Hold |
40,000
| – | – | 0.02% | 427 |
|
|
2015
Q1 | $1.22M | Buy |
+40,000
| New | +$1.22M | 0.02% | 434 |
|